LND topic: novo-nordisk page 1

novo nordisk

Wegovy's Strong Start: Novo Nordisk Shares Jump

January 16, 2026

Novo Nordisk's shares got a nice boost on Friday. They went up by more than 5% after some early reports came out. These reports showed that their new obesity pill, Wegovy, is doing well in the U. S. market. The pill, which is the first of its kind for weight loss, had a good start. But experts say

health

Amazon Pharmacy Joins the Weight Loss Drug Game

January 9, 2026

Amazon Pharmacy has started selling Novo Nordisk's new weight loss pill, Wegovy. This pill is a big deal because it's the first oral version of a drug that was previously only available as an injection. The price is also quite attractive, with cash-paying customers able to get it for $149 a month. T

health

A New Weight Loss Hope: Wegovy's Bigger Dose Gets Green Light in Europe

December 13, 2025

The European Medicines Agency (EMA) has given a thumbs-up to Novo Nordisk's higher dose of Wegovy. This is big news for people struggling with weight. The EMA's committee said the new dose, semaglutide 7. 2 mg, is good to go. Novo Nordisk also wants to make it easier to use. They've applied for a si

health

Ozempic and Wegovy: A New Price Breakdown

November 19, 2025

Novo Nordisk has introduced a new pricing strategy for its weight-loss drugs, Ozempic and Wegovy. Starting now, people without insurance can buy the lowest doses for $199 a month for two months. After that, the price jumps to $349. This deal is available through the drugs' websites and select pharma

health

A New Player in the Weight Loss Pill Game

August 24, 2025

Eli Lilly is making waves in the weight loss drug market with its new obesity pill, orforglipron. This pill is set to compete with Novo Nordisk's oral semaglutide, which has shown promising results. Both drugs work by mimicking a gut hormone called GLP-1 to help control appetite and blood sugar leve

finance

Danish Drug Giant Shakes Up Leadership Amid Market Storm

May 16, 2025

A major shakeup is happening at Novo Nordisk. The company's CEO, Lars Fruergaard Jørgensen, is stepping down. This move comes as the company faces tough times in the market. Novo Nordisk is known for its weight-loss drugs, like Wegovy. But lately, things haven't been easy for them. The pharmaceutic

health

Semaglutide Showdown: FDA and Big Pharma Take On Compounders

April 25, 2025

The battle over semaglutide, the active ingredient in popular diabetes and weight loss drugs, has reached a critical point. A federal judge in Texas recently ruled against compounding pharmacies, siding with a major drug manufacturer. This decision means that these pharmacies can no longer produce c

business

Novo Nordisk's New Weight-Loss Drug Fails to Impress Investors

December 20, 2024

Novo Nordisk, a big player in Europe's pharma scene, saw its shares take a huge hit on Friday. Why? Their latest weight-loss drug, CagriSema, didn't meet expectations. The drug helped patients lose about 22. 7% of their body weight in late-stage trials, but that was barely better than Eli Lilly's ri

business

The SEC Opens Up Bitcoin Options Trading

October 22, 2024

This morning, there's a lot to unpack! Did you know that McDonald's distanced itself from Trump's drive-through stunt? They're claiming no involvement in his surprise fast-food appearance. On a health note, Novo Nordisk's Ozempic pill might reduce heart attack and stroke risks, according to a fresh

politics

Why Are U.S. Weight Loss Drug Prices So High?

October 7, 2024

Lawmakers have been questioning Novo Nordisk, the company behind popular weight loss drugs Ozempic and Wegovy. The Senate wants to know why these medications are priced so much higher in the U.S. compared to other countries. For example, Americans with diabetes pay $969 per month for Ozempic, while